Andy Chevigné and his crew, RTI-5152-12 is postulated to enhance the levels of opioid peptides that bind to classical opioid receptors while in the Mind, leading to heightened painkilling action. The LIH-RTI investigation groups set up a collaboration agreement and filed a joint patent software in December 2020. At https://cordellz394ttu5.wikilentillas.com/user